Image

The Use of Thrombin Generation Assay in Detection of Central Line Related Thrombosis (CRT) in Critically Ill Patients

Recruiting
18 - 100 years of age
Both
Phase N/A

Powered by AI

Overview

To study thrombin generation parameters in critically ill patients with and without central line related thrombosis (CRT).

Eligibility

Inclusion Criteria:

  • Age ≧ 18; AND
  • Admitted to the mixed medical-surgical intensive care units of Queen Mary Hospital in Hong Kong; AND
  • Clinically indicated for central catheter insertion, which includes central venous catheters and dialysis catheters; AND
  • Expected to have the central catheter in place for at least 5 days in their ICU stay.

Exclusion Criteria:

  • Patients known to have active venous thromboembolism including deep venous thrombosis or pulmonary embolism;
  • Patients known to have hypercoagulable states, e.g., hereditary thrombophilia, antiphospholipid syndrome; OR
  • Patients with active solid organ or hematological malignancies; OR
  • Patients already receiving therapeutic anticoagulation prior to study recruitment; OR
  • Patients with thrombosis detected in the insertion site before central catheter insertion; OR
  • Patients with a central venous catheter already in place prior to ICU admission; OR
  • Patients admitted to the ICU for post-operative care; OR
  • Patients admitted to the ICU for trauma care; OR
  • Patients requiring extra-corporeal life support (ECLS); OR
  • Patients with poor window or inaccessible for ultrasonographic examination; OR
  • Pregnancy/post-partum within 6 weeks

Study details

Central Line Complication, Thrombosis, Venous

NCT06094387

Queen Mary Hospital, Hong Kong

17 April 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.